Colvin Christopher J
a Division of Social and Behavioural Sciences and the Centre for Infectious Disease Epidemiology and Research (CIDER), School of Public Health and Family Medicine , University of Cape Town , Cape Town , South Africa.
Glob Public Health. 2014;9(1-2):57-72. doi: 10.1080/17441692.2014.881519. Epub 2014 Feb 5.
The HIV epidemic is widely recognised as having prompted one of the most remarkable intersections ever of illness, science and activism. The production, circulation, use and evaluation of empirical scientific 'evidence' played a central part in activists' engagement with AIDS science. Previous activist engagement with evidence focused on the social and biomedical responses to HIV in the global North as well as challenges around ensuring antiretroviral treatment (ART) was available in the global South. More recently, however, with the roll-out and scale-up of large public-sector ART programmes and new multi-dimensional prevention efforts, the relationships between evidence and activism have been changing. Scale-up of these large-scale treatment and prevention programmes represents an exciting new opportunity while bringing with it a host of new challenges. This paper examines what new forms of evidence and activism will be required to address the challenges of the scaling-up era of HIV treatment and prevention. It reviews some recent controversies around evidence and HIV scale-up and describes the different forms of evidence and activist strategies that will be necessary for a robust response to these new challenges.
人们普遍认识到,艾滋病病毒疫情引发了疾病、科学与行动主义之间最显著的交集之一。经验性科学“证据”的产生、传播、使用和评估在行动主义者参与艾滋病科学研究中发挥了核心作用。以往行动主义者对证据的关注集中在全球北方对艾滋病毒的社会和生物医学应对措施,以及在全球南方确保提供抗逆转录病毒治疗(ART)所面临的挑战。然而,最近随着大型公共部门抗逆转录病毒治疗项目的推出和扩大以及新的多层面预防措施的实施,证据与行动主义之间的关系一直在发生变化。扩大这些大规模治疗和预防项目代表着一个令人兴奋的新机遇,同时也带来了一系列新挑战。本文探讨应对艾滋病毒治疗和预防扩大时代的挑战需要哪些新的证据形式和行动主义形式。它回顾了最近围绕证据和艾滋病毒扩大规模的一些争议,并描述了对这些新挑战做出有力回应所需的不同证据形式和行动主义策略。